Home
Monoclonal Antibodies .net
Thanks for visiting our website. Our website reviews the production of monoclonal antibodies and the services that we can provide to generate custom antibodies monoclonal. Our company VRISKO LTD is specialized in antibody production including mouse monoclonal antibody production using hybridoma technology.
Monoclonal antibodies
Production of monoclonal antibodies
There are two different methods for the production monoclonal antibodies: hybridoma technology and recombinant antibody technology. For production of recombinant antibodies visit our website www.protein-engineering.eu or our company website www.vrisko.net.
Production of monoclonal antibodies by the hybridoma technology.
The hybridoma technology was developed by the scientists Niels K. Jerne, Georges Köhler and Cesar Milstein who were awarded Nobel prize in Physiology or Medicine in 1984 for this contribution to the science. The hybridoma technique consists in extracting B lymphocytes from the spleen of a laboratory animal (e.g. mice) that had been first exposed to an antigen to which we are interested in isolating an antibody against. The B cells can secrete antibodies monoclonal but not in a significant quantity and do not survive for long. The specific antibody producing B-cells are fused with myeloma cells which is a type of cancer cell line, which grow indefinitely in cell culture. Also the key in the hybridoma technology is the fusion of the two cell types, one is programmed to produce specific antibodies monoclonal but without the capacity of multiplying indefinitely and the other immortal with high capacity to grow but without the capacity of producing antibodies. The resulting cells, called hybridoma, will have the capacity to multiply quickly and indefinitely and to produce high quantity of monoclonal antibodies. During the process the cells are diluted to obtain one cell per well. The antibodies produced by different clones are analyzed to determine their capacity to bind the antigen. By this way the positive clones are selected and isolated. See a picture of the hybridoma technology. The monoclonal antibodies can be produced in cell culture or in laboratory animals. When the hybridoma cells are injected in the peritoneal cavity of a mouse, it will produce a tumor which synthesize a fluid rich in antibodies called ascitic liquid.
Our antibody production services
VRISKO LTD delivers antibody services of high quality and to a low cost. We are committed to provide the highest level of products and antibody services.
Production of monoclonal antibodies
Production of monoclonal antibodies
Production of monoclonal antibodies can be obtained by purchasing our services. We provide high quality production of monoclonal antibodies at a low price.
Mouse Monoclonal Antibody Production
The Custom production of monoclonal antibodies Basic package includes production of monoclonal antibodies by the hybridoma technology. In this package is not included recombinant protein expression, recombinant protein production or peptide synthesis used to humanized the mouse.
Basic package
- Immunization (5 mice/antigen) and Sera Testing by ELISA.
- Fusion and Colony Screening.
- Subcloning, Colony Expansion and Freezing.
- Guaranteed western blot positive clones (2 clones)
- Antibody Purification from Ascites by Protein A/G (2 clones, 3mg each)
* Customer to provide plasmid in expression vector with HIS or GST tag. The customer can provide a peptide antigen or a ready-to-inject antigen for monoclonal antibody production. When using a peptide antigen supplied by the customer, an additional charge is applied for KLH conjugation.
Price: $4200
Cat#: VS001
Antibody production
Complete package
Our complete package provides antigen production (recombinant protein) and antibody production
- Recombinant protein production
- Immunization (5 mice/antigen) and Sera Testing by ELISA
- Fusion and Colony Screening
- Subcloning, Colony Expansion and Freezing
- Guaranteed western blot positive clones (2 clones)
- Antibody Purification from Ascites by Protein A/G (2 clones, 3mg each)
Price $ 6200 Cat#VS002
Relating websites:
- Visit our mirror website relating to antibody production, production of monoclonal antibodies, antibody, antibodies monoclonal, and hybridoma.
- Visit our company website www.vrisko.net.
———————————————————————————————-
News about monoclonal antibodies
mAb news
Cell Signaling Technology, Inc. Develops Novel Monoclonal Antibody Discovery ...
MarketWatch (press release)
DANVERS, Mass., May 11, 2012 (BUSINESS WIRE) -- Cell Signaling Technology, Inc. (CST) of Danvers, MA is pleased to announce the development of a new discovery platform for antigen-specific monoclonal antibodies. This novel antibody discovery technology ...and more » CytoDyn completes production of FIV monoclonal antibodies
Pharmaceutical Business Review
CytoFeline is a monoclonal antibody developed for the treatment of Feline Immunodeficiency Virus (FIV). Up on the completion of antibody purification, CVM will determine the practicality of anti-LFA1 antibodies to lower viral loads in FIV-infected cats ...Australian Institute for Bioengineering and Nanotechnology and Biosceptre ...
Nanowerk LLC
Under the UniQuest agreement, the AIBN's National Biologics Facility (NBF) will characterise candidate therapeutic monoclonal antibodies that bind Biosceptre's novel proprietary cancer target, known as nf-P2X7. The research and development will include ...Theraclone Sciences Announces Positive Top-line Data from a Phase 1 Trial of ...
MarketWatch (press release)
SEATTLE, May 15, 2012 (BUSINESS WIRE) -- Theraclone Sciences, Inc., a therapeutic antibody discovery and development company, today announced positive top-line data from its Phase 1 trial of TCN-032, a broadly protective, fully human monoclonal ...and more » CST develops new monoclonal antibody discovery platform
Pharmaceutical Business Review
Cell Signaling Technology (CST) has developed monoclonal antibody discovery platform, NG-XMT, for antigen-specific monoclonal antibodies. The antibody discovery technology combines the power of proteomics to identify and clone antigen-specific ...Theraclone Sciences Announces Positive Top-line Data from a Phase 1 Trial of ...
EON: Enhanced Online News (press release)
SEATTLE--(EON: Enhanced Online News)--Theraclone Sciences, Inc., a therapeutic antibody discovery and development company, today announced positive top-line data from its Phase 1 trial of TCN-032, a broadly protective, fully human monoclonal antibody, ...and more » Intellect Neurosciences Expands Its Immunotherapy Pipeline with New Technology ...
MarketWatch (press release)
The patent applications are based on Intellect's discovery that chemically stabilized protein aggregates present in Huntington's and Parkinson's disease, among others, can be used as immunogens to produce monoclonal antibodies that selectively detect ...and more » Researchers Present Data Highlighting Potential of Peregrine's PS-Targeting ...
MarketWatch (press release)
TUSTIN, CA, May 10, 2012 (MARKETWIRE via COMTEX) -- Peregrine Pharmaceuticals, Inc. (UTD:PPHM) , a clinical-stage biopharmaceutical company developing first-in-class monoclonal antibodies for the treatment and diagnosis of cancer and infectious ...and more » Intellect Neurosciences, Inc. to Present at Neurotech Investing and Partnering ...
MarketWatch (press release)
The company currently is developing products based on three platform technologies: ANTISENILIN® is Intellect's Alzheimer's beta amyloid monoclonal antibody platform technology, which underlies a product in Phase 3 clinical trials and is licensed to ...5W Public Relations Named PR Agency of Record for IMMUNE Pharmaceuticals
MarketWatch (press release)
IMMUNE Pharmaceuticals is an Israel and US based biopharmaceutical company focused on the development of next generation monoclonal antibodies addressing significant unmet medical needs in the treatment of inflammatory diseases and cancer.and more »
We are listed on:
www.biology-online.org Improve your marketing with the best web directories This site is listed under Biotechnology Directory